167 related articles for article (PubMed ID: 21194074)
1. [BMS-790 052 - an oral antiviral hepatitis C antiviral in the pipeline].
Schmitz J
Pharm Unserer Zeit; 2011 Jan; 40(1):8-9. PubMed ID: 21194074
[No Abstract] [Full Text] [Related]
2. Novel hepatitis C drugs in current trials.
Kronenberger B; Welsch C; Forestier N; Zeuzem S
Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus.
Gamble C; Trotard M; Le Seyec J; Abreu-Guerniou V; Gernigon N; Berrée F; Carboni B; Felden B; Gillet R
Bioorg Med Chem Lett; 2009 Jul; 19(13):3581-5. PubMed ID: 19450979
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin: is it a mutagen for hepatitis C virus?
Perelson AS; Layden TJ
Gastroenterology; 2007 May; 132(5):2050-2. PubMed ID: 17484896
[No Abstract] [Full Text] [Related]
5. Hepatitis C: changing genotype distribution with important implications for patient management.
van Soest H; Boland GJ; van Erpecum KJ
Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
[TBL] [Abstract][Full Text] [Related]
6. Current therapy of hepatitis C.
de Knegt RJ
Scand J Gastroenterol Suppl; 2006; (243):65-9. PubMed ID: 16782624
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial investigates two experimental HCV drugs.
AIDS Patient Care STDS; 2010 Apr; 24(4):270. PubMed ID: 20402017
[No Abstract] [Full Text] [Related]
8. Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?
Shire N; Koziel MJ
Clin Infect Dis; 2004 Dec; 39(12):1761-3. PubMed ID: 15578396
[No Abstract] [Full Text] [Related]
9. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
Trepanier JB; Tanner JE; Alfieri C
Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
[TBL] [Abstract][Full Text] [Related]
10. Tailoring antiviral therapy in hepatitis C.
Davis GL
Hepatology; 2006 May; 43(5):909-11. PubMed ID: 16628667
[No Abstract] [Full Text] [Related]
11. Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates.
Neyts J; De Clercq E; Singha R; Chang YH; Das AR; Chakraborty SK; Hong SC; Tsay SC; Hsu MH; Hwu JR
J Med Chem; 2009 Mar; 52(5):1486-90. PubMed ID: 19193060
[TBL] [Abstract][Full Text] [Related]
12. Tailored treatment for hepatitis C.
Berg T
Clin Liver Dis; 2008 Aug; 12(3):507-28, vii-viii. PubMed ID: 18625426
[TBL] [Abstract][Full Text] [Related]
13. [Structure and replication of viral hepatitis C virus, the key of the future therapeutic goals].
Grigorescu O; Luca CM; Moraru E
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):877-81. PubMed ID: 20209756
[TBL] [Abstract][Full Text] [Related]
14. Challenges and successes in developing new therapies for hepatitis C.
De Francesco R; Migliaccio G
Nature; 2005 Aug; 436(7053):953-60. PubMed ID: 16107835
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.
Lee JH; Teuber G; von Wagner M; Roth WK; Zeuzem S
J Med Virol; 2000 Mar; 60(3):264-8. PubMed ID: 10630957
[TBL] [Abstract][Full Text] [Related]
16. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
17. Treating patients with HCV genotype 1 and low viraemia: more than meets the eye.
Craxì A; Cammà C
J Hepatol; 2006 Jan; 44(1):4-7. PubMed ID: 16293337
[No Abstract] [Full Text] [Related]
18. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
19. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
[No Abstract] [Full Text] [Related]
20. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
